Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer.
FI: 2,926
Type: Article
Collaboration
Year: 2016
Writers
Pompas-Veganzones, N; Sandonis, V; Perez-Lanzac, A; Beltran, M.; Beardo, P; Juárez, A; Vazquez, F.; Cozar, JM; Alvarez-Ossorio, JL; Sanchez-Carbayo, M.
Magazine
Title: TUMOR BIOLOGY
Quartile
- Q2